Cellular and molecular abnormalities of a macronodular adrenal hyperplasia causing beta-blocker-sensitive Cushing's syndrome

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 51, Issue 9, 2007, Pages 1452-1462

  Mazzuco, Tânia Longo ^a,b,d   Thomas, Michaël ^a   Martinie, Monique ^b   Cherradi, Nadia ^a   Sturm, Nathalie ^c   Feige, Jean Jacques ^a   Chabre, Olivier ^a,b  

^a CEA GRENOBLE   (France)

^b Département de Diabétologie Urologie Néphrologie Endocrinologie DUNE

^c GRENOBLE UNIVERSITY HOSPITAL   (France)

^d STATE UNIVERSITY OF LONDRINA   (Brazil)

Author keywords

Adrenal glands (pathol); Adrenocortical hyperfunction; Adrenocorticotropic hormone; Cell surface; Cushing syndrome; Hormone receptors; Hyperplasia

Indexed keywords

EID: 38849184066     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/s0004-27302007000900007     Document Type: Article

References (42)

1. Lacroix A, Baldacchino V, Bourdeau I, Hamet P, Tremblay J. Cushing's syndrome variants secondary to aberrant hormone receptors. Trends Endocrinol Metab 2004;15:375-82.
2. Lacroix A, Tremblay J, Rousseau G, Bouvier M, Hamet P. Propranolol therapy for ectopic beta-adrenergic receptors in adrenal Cushing's syndrome. N Engl J Med 1997;337:1429-34.
3. Mircescu H, Jilwan J, N'Diaye N, Bourdeau I, Tremblay J, Hamet P, et al. Are ectopic or abnormal membrane hormone receptors frequently present in adrenal Cushing's syndrome? J Clin Endocrinol Metab 2000;85:3531-6.
4. Mazzuco TL, Martinie M, Favre S, Bachelot I, Chabre O. ACTH-independent Cushing's syndrome treated solely with propranolol therapy. The Endocrine Society's 84th Meeting; 2002. San Francisco, CA.
5. Imohl M, Koditz R, Stachon A, Muller KM, Nicolas V, Pfeilschifter J, et al. [Catecholamine-dependent hereditary Cushing's syndrome - follow-up after unilateral adrenalectomy]. Med Klin (Munich) 2002;97:747-53.
6. Miyamura N, Tsutsumi A, Senokuchi H, Nakamaru K, Kawashima J, Sakai K, et al. A case of ACTH-independent macronodular adrenal hyperplasia: simultaneous expression of several aberrant hormone receptors in the adrenal gland. Endocr J 2003;50:333-40.
7. Pignatelli D, Rodrigues E, Barbosa AP, Medina JL. Cushing syndrome due to the ectopic expression of adrenergic receptors in the adrenal cortex. A Case of ACTH Independent Macronodular Adrenal Hyperplasia (AIMAH). The Endocrine Society's 86th Meeting; 2004. New Orleans, LA.
8. Schorr I, Rathnam P, Saxena BB, Ney RL. Multiple specific hormone receptors in the adenylate cyclase of an adrenocortical carcinoma. J Biol Chem 1971;246:5806-11.
9. Williams LT, Gore TB, Lefkowitz RJ. Ectopic beta-adrenergic receptor binding sites. Possible molecular basis of aberrant catecholamine responsiveness of an adrenocortical tumor adenylate cyclase. J Clin Invest 1977;59:319-24.
10. Matsukura S, Kakita T, Sueoka S, Yoshimi H, Hirata Y, Yokota M, et al. Multiple hormone receptors in the adenylate cyclase of human adrenocortical tumors. Cancer Res 1980;40:3768-71.
11. Katz MS, Kelly TM, Dax EM, Pineyro MA, Partilla JS, Gregerman RI. Ectopic beta-adrenergic receptors coupled to adenylate cyclase in human adrenocortical carcinomas. J Clin Endocrinol Metab 1985;60:900-9.
12. Hirata Y, Uchihashi M, Sueoka S, Matsukura S, Fujita T. Presence of ectopic beta-adrenergic receptors on human adrenocortical cortisol-producing adenomas. J Clin Endocrinol Metab 1981;53:953-7.
13. Lacroix A, Hamet P, Boutin JM. Clinical evaluation of the presence of abnormal hormone receptors in adrenal Cushing's syndrome. Endocrinologist 1999;9:9-15.
14. Perraudin V, Delarue C, De Keyzer Y, Bertagna X, Kuhn JM, Contesse V, et al. Vasopressin-responsive adrenocortical tumor in a mild Cushing's syndrome: in vivo and in vitro studies. J Clin Endocrinol Metab 1995;80:2661-7.
15. Lefebvre H, Cartier D, Duparc C, Lihrmann I, Contesse V, Delarue C, et al. Characterization of serotonin(4) receptors in adrenocortical aldosterone-producing adenomas: in vivo and in vitro studies. J Clin Endocrinol Metab 2002;87:1211-6.
16. Bertherat J, Contesse V, Louiset E, Barrande G, Duparc C, Groussin L, et al. In vivo and in vitro screening for illegitimate receptors in adrenocorticotropin-independent macronodular adrenal hyperplasia causing Cushing's syndrome: identification of two cases of gonadotropin/gastric inhibitory polypeptide-dependent hypercortisolism. J Clin Endocrinol Metab 2005;90:1302-10.
17. Smith C, Teitler M. Beta-blocker selectivity at cloned human beta 1- and beta 2-adrenergic receptors. Cardiovasc Drugs Ther 1999;13:123-6.
18. Wood AJ. Pharmacologic differences between beta blockers. Am Heart J 1984;108:1070-7.
19. Kawamura M, Nakamichi N, Imagawa N, Tanaka Y, Tomita C, Matsuba M. Effect of adrenaline on steroidogenesis in primary cultured bovine adrenocortical cells. Jpn J Pharmacol 1984;36:35-41.
20. Thomas RF, Liggett SB. Lack of beta 3-adrenergic receptor mRNA expression in adipose and other metabolic tissues in the adult human. Mol Pharmacol 1993;43:343-8.
21. Boksa P. Studies on the uptake and release of propranolol and the effects of propranolol on catecholamines in cultures of bovine adrenal chromaffin cells. Biochem Pharmacol 1986;35:805-15.
22. Kosti O, King PJ, Hinson JP. Tumour-derived human adrenocortical cells express beta-adrenergic receptors: steroidogenic effects of beta-adrenergic input. Endocr Res 2002;28:363-7.
23. Tatsuno I, Uchida D, Tanaka T, Koide H, Shigeta A, Ichikawa T, et al. Vasopressin responsiveness of subclinical Cushing's syndrome due to ACTH-independent macronodular adrenocortical hyperplasia. Clin Endocrinol (Oxf) 2004;60:192-200.
24. Mannelli M, Ferruzzi P, Luciani P, Crescioli C, Buci L, Corona G, et al. Cushing's syndrome in a patient with bilateral macronodular adrenal hyperplasia responding to cisapride: an in vivo and in vitro study. J Clin Endocrinol Metab 2003;88:4616-22.
25. Cartier D, Lihrmann I, Parmentier F, Bastard C, Bertherat J, Caron P, et al. Overexpression of serotonin4 receptors in cisapride-responsive adrenocorticotropin-independent bilateral macronodular adrenal hyperplasia causing Cushing's syndrome. J Clin Endocrinol Metab 2003;88:248-54.
26. Mune T, Murase H, Yamakita N, Fukuda T, Murayama M, Miura A, et al. Eutopic overexpression of vasopressin v1a receptor in adrenocorticotropin- independent macronodular adrenal hyperplasia. J Clin Endocrinol Metab 2002;87:5706-13.
27. Lefebvre H, Contesse V, Delarue C, Soubrane C, Legrand A, Kuhn JM, et al. Effect of the serotonin-4 receptor agonist zacopride on aldosterone secretion from the human adrenal cortex: in vivo and in vitro studies. J Clin Endocrinol Metab 1993;77:1662-6.
28. Pindon A, van Hecke G, van Gompel P, Lesage AS, Leysen JE, Jurzak M. Differences in signal transduction of two 5-HT4 receptor splice variants: compound specificity and dual coupling with Galphas- and Galphai/o-proteins. Mol Pharmacol 2002;61:85-96.
29. Arnaldi G, Gasc JM, de Keyzer Y, Raffin-Sanson ML, Perraudin V, Kuhn JM, et al. Variable expression of the V1 vasopressin receptor modulates the phenotypic response of steroid-secreting adrenocortical tumors. J Clin Endocrinol Metab 1998;83:2029-35.
30. Mazzuco TL, Chabre O, Sturm N, Feige JJ, Thomas M. Ectopic expression of the gastric inhibitory polypeptide receptor gene is a sufficient genetic event to induce benign adrenocortical tumor in a xenotransplantation model. Endocrinology 2006;147:782-90.
31. Mazzuco TL, Chabre O, Feige JJ, Thomas M. Aberrant expression of human luteinizing hormone receptor by adrenocortical cells is sufficient to provoke both hyperplasia and Cushing's syndrome features. J Clin Endocrinol Metab 2006;91:196-203.
32. Mazzuco TL, Chabre O, Feige JJ, Thomas M. Aberrant GPCR expression is a sufficient genetic event to trigger adrenocortical tumorigenesis. Mol Cell Endocrinol 2007;265-266:23-8.
33. Antonini SR, N'Diaye N, Baldacchino V, Hamet P, Tremblay J, Lacroix A. Analysis of the putative regulatory region of the gastric inhibitory polypeptide receptor gene in food-dependent Cushing's syndrome. J Steroid Biochem Mol Biol 2004;91:171-7.
34. Baldacchino V, Oble S, Decarie PO, Bourdeau I, Hamet P, Tremblay J, et al. The Sp transcription factors are involved in the cellular expression of the human glucose-dependent insulinotropic polypeptide receptor gene and overexpressed in adrenals of patients with Cushing's syndrome. J Mol Endocrinol 2005;35:61-71.
35. Lampron A, Bourdeau I, Hamet P, Tremblay J, Lacroix A. Whole genome expression profiling of glucose-dependent insulinotropic peptide (GIP)- and adrenocorticotropin-dependent adrenal hyperplasias reveals novel targets for the study of GIP-dependent Cushing's syndrome. J Clin Endocrinol Metab 2006;91:3611-8.
36. Daidoh H, Morita H, Hanafusa J, Mune T, Murase H, Sato M, et al. In vivo and in vitro effects of AVP and V1a receptor antagonist on Cushing's syndrome due to ACTH-independent bilateral macronodular adrenocortical hyperplasia. Clin Endocrinol (Oxf) 1998;49:403-9.
37. Mircescu H, Jilwan J, N'Diaye N, Bourdeau I, Tremblay J, Hamet P, et al. Are ectopic or abnormal membrane hormone receptors frequently present in adrenal Cushing's syndrome? J Clin Endocrinol Metab 2000;85:3531-6.
38. Lacroix A, Tremblay J, Rousseau G, Bouvier M, Hamet P. Propranolol therapy for ectopic beta-adrenergic receptors in adrenal Cushing's syndrome. N Engl J Med 1997;337:1429-34.
39. Lefebvre H, Duparc C, Chartrel N, Jegou S, Pellerin A, Laquerriere A, et al. Intraadrenal adrenocorticotropin production in a case of bilateral macronodular adrenal hyperplasia causing Cushing's syndrome. J Clin Endocrinol Metab 2003;88:3035-42.
40. Willenberg HS, Bornstein SR, Hiroi N, Path G, Goretzki PE, Scherbaum WA, et al. Effects of a novel corticotropin-releasing-hormone receptor type I antagonist on human adrenal function. Mol Psychiatry 2000;5:137-41.
41. Suda T, Tomori N, Tozawa F, Demura H, Shizume K, Mouri T, et al. Immunoreactive corticotropin and corticotropin-releasing factor in human hypothalamus, adrenal, lung cancer, and pheochromocytoma. J Clin Endocrinol Metab 1984;58:919-24.
42. Pereira MA, Araújo RS, Bisi H. Síndrome de Cushing associada à hiperplasia macronodular das adrenais: apresentaç ão de um caso e revisão da literatura. Arq Bras Endocrinol Metab 2001;45:619-27.